• head_banner_01

Quality Inspection for Cephapirinbenzathine - Atosiban Acetate Used for Anti Premature Birth – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

We keep on with the theory of "quality first, provider initially, constant improvement and innovation to meet the customers" with the management and "zero defect, zero complaints" as the standard objective. To great our company, we deliver the merchandise using the fantastic excellent at the reasonable price for Benzyl Chromium Chloride, Vardenafil, Benzalkonium Chloride Use, As a leading manufacture and exporter, we enjoy a good reputation in the international markets, especially in America and Europe, because of our top quality and reasonable prices.
Quality Inspection for Cephapirinbenzathine - Atosiban Acetate Used for Anti Premature Birth – Gentolex Detail:

Product Detail

Name  Atosiban
CAS number  90779-69-4
Molecular formula  C43H67N11O12S2
Molecular weight  994.19
EINECS Number  806-815-5
Boiling point  1469.0±65.0 °C (Predicted)
Density  1.254±0.06 g/cm3(Predicted)
Storage conditions  -20°C
Solubility  H2O:≤100 mg/mL

Description

Atosiban acetate is a disulfide-bonded cyclic polypeptide consisting of 9 amino acids. It is a modified oxytocin molecule at positions 1, 2, 4 and 8. The N-terminus of the peptide is 3-mercaptopropionic acid (thiol and The sulfhydryl group of [Cys]6 forms a disulfide bond), the C-terminal is in the form of an amide, the second amino acid at the N-terminal is an ethylated modified [D-Tyr(Et)]2, and atosiban acetate is used in medicines as vinegar It exists in the form of an acid salt, commonly known as atosiban acetate.

Application

Atosiban is an oxytocin and vasopressin V1A combined receptor antagonist, the oxytocin receptor is structurally similar to the vasopressin V1A receptor. When the oxytocin receptor is blocked, oxytocin can still act through the V1A receptor, so it is necessary to block the above two receptor pathways at the same time, and a single antagonism of one receptor can effectively inhibit uterine contraction. This is also one of the main reasons why β-receptor agonists, calcium channel blockers and prostaglandin synthase inhibitors cannot effectively inhibit uterine contractions.

Effect

Atosiban is a combined receptor antagonist of oxytocin and vasopressin V1A, its chemical structure is similar to the two, and it has a high affinity for receptors, and competes with oxytocin and vasopressin V1A receptors, thereby blocking the action pathway of oxytocin and vasopressin and reducing uterine contractions.


Product detail pictures:

Quality Inspection for Cephapirinbenzathine - Atosiban Acetate Used for Anti Premature Birth – Gentolex detail pictures

Quality Inspection for Cephapirinbenzathine - Atosiban Acetate Used for Anti Premature Birth – Gentolex detail pictures


Related Product Guide:

"Quality initial, Honesty as base, Sincere support and mutual profit" is our idea, so as to build repeatedly and pursue the excellence for Quality Inspection for Cephapirinbenzathine - Atosiban Acetate Used for Anti Premature Birth – Gentolex , The product will supply to all over the world, such as: Algeria, Argentina, Luxembourg, We insist on "Quality First, Reputation First and Customer First". We are committed to providing high-quality products and good after-sales services. Up to now, our products have been exported to more than 60 countries and areas around the world, such as America, Australia and Europe. We enjoy a high reputation at home and abroad. Always persisting in the principle of "Credit, Customer and Quality", we expect cooperation with people in all walks of life for mutual benefits.
  • Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
    5 Stars By Eden from UAE - 2018.12.10 19:03
    The goods we received and the sample sales staff display to us have the same quality, it is really a creditable manufacturer.
    5 Stars By Betty from New Zealand - 2017.12.09 14:01
    Write your message here and send it to us